Duke policy provides ethical foundation for managing drug shortages

September 24, 2012

Hospitals and health systems faced with ongoing shortages of key drugs for cancer and other diseases should develop firm rationing policies based on transparency and fairness, researchers at Duke University Medical Center report.

In a Special Article published online Monday, Sept. 24, 2012 in the , the Duke team outlined a policy adopted at Duke Medical Center that established clear-cut rules for apportioning scarce drugs using a hierarchy of clinical need and effectiveness.

Built on similar models that govern some organ donations, the Duke approach was written by the hospital's ethics committee and adopted by hospital leadership in 2011 as shortages of critical drugs occurred regularly.

In recent years, the U.S. has announced hundreds of supply problems for lifesaving , , and other drugs. Dozens of pharmaceuticals are on the shortage list at any given time, forcing doctors to switch patients to alternatives, delay treatments or cut dosages.

"There's no reason to believe things will get better and, in fact, they may get worse, so hospitals will have to deal with some very dicey issues," said Philip M. Rosoff, M.D., M.A., director of at Duke and lead author of the study. "For that reason, it's important to establish and follow an ethically defensible policy for how scarce resources are rationed."

In their article describing the development and implementation of the Duke Medical Center policy, Rosoff and co-authors outlined five essential components:

  • Rules were transparent and open to review both internally and externally;
  • The policy and its rationale were relevant, clinically necessary and clearly stated;
  • Patients and doctors had a path for appeal;
  • Rules were followed and enforced by all and for all;
  • No patient or doctor was allowed special consideration.
Rosoff said fairness was an especially important component of the policy.

"One of the issues that arises is the question of so-called 'special people,'" Rosoff said. "What if a major donor comes in, or someone who says they'd like to be a major donor? Does that person step to the front of the line? Our policy says no – all patients are treated equal."

While each shortage was unique, Rosoff said having the policy provided a uniform approach to managing different situations. When drugs were flagged as running low, hospital officials immediately responded by taking inventory of remaining stock, determining when and how additional supplies might become available, reducing waste and paring back on usage.

One tactic was to restrict scarce drugs for FDA-approved uses, or in circumstances with firm, scientific evidence of benefit. As a result, a agent approved solely for breast cancer could not be used "off label" for other types of cancers unless there was strong published evidence to support it.

Hospital officials also strategically scheduled patients who needed the same drugs on the same day, pooling the small leftover amounts in single vial containers to reduce waste.

In certain critical shortage situations, Duke also had rules giving priority to existing patients, new patients from the immediate referral region, and patients who could be cured by the drug.

Rosoff said Duke's experience could be instructive to most other institutions, but noted that the hospital benefitted from having a compounding pharmacy, which enabled it to produce many scarce drugs when raw materials were available. He said that capacity created additional ethical dilemmas, requiring strong communication and cooperation with surrounding hospitals.

"We had to make some difficult decisions, most of which we foresaw in the creation of the policy," Rosoff said. "There have been several issues we thought could happen, but haven't happened yet, so in that sense, it's been very gratifying."

Explore further: Anti-infective drug shortages pose threat to public health and patient care

Related Stories

Anti-infective drug shortages pose threat to public health and patient care

January 20, 2012
Shortages of key drugs used to fight infections represent a public health emergency and can put patients at risk, according to a review published in Clinical Infectious Diseases and available online. Frequent anti-infective ...

FDA: New suppliers to ease 2 cancer drug shortages

February 21, 2012
Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages - at least for the time being - that have patients worried about missing life-saving treatments.

Canada needs national approach to protect against drug shortages

August 20, 2012
Canada needs a national approach to managing its supply of pharmaceutical drugs, starting with a mandatory reporting system for drug shortages, argues an editorial in CMAJ (Canadian Medical Association Journal) and CPJ (Canadian ...

Recommended for you

Glucocorticoids offer long-term benefits for patients with Duchenne muscular dystrophy

November 22, 2017
Glucocorticoids, a class of steroid hormone medications often prescribed to patients with Duchenne muscular dystrophy (DMD), offer long-term benefits for this disease, including longer preservation of muscle strength and ...

Baby-boomers and millennials more afflicted by the opioid epidemic

November 21, 2017
Baby-boomers, those born between 1947 and 1964, experienced an excess risk of prescription opioid overdose death and heroin overdose death, according to latest research at Columbia University's Mailman School of Public Health. ...

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.